Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
41%
OVERLAP
BY WEIGHT
41
# OF OVERLAPPING
HOLDINGS
XBI
139
HOLDINGS
31%
ALSO IN BBP
BBP
57
HOLDINGS
67%
ALSO IN XBI
SECTOR DRIFT (XBI minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
TRAVERE THERAPEUTICS, INC. | 1.4% | 2.0% | 1.4% |
|
EXELIXIS INC | 1.4% | 1.8% | 1.4% |
|
BIOMARIN PHARMACEUTICAL INC | 1.3% | 1.4% | 1.3% |
|
HALOZYME THERAPEUTICS INC | 1.3% | 2.6% | 1.3% |
 |
ROIVANT SCIENCES LTD. | 1.3% | 1.8% | 1.3% |
XBI Overweight Relative to BBP
|
VAXCYTE, INC. | 1.3% |
|
CYTOKINETICS INC | 1.3% |
|
REVOLUTION MEDICINES, INC. | 1.2% |
|
ABBVIE INC | 1.2% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.2% |
|
SCHOLAR ROCK HOLDING CORP. | 1.2% |
|
AVIDITY BIOSCIENCES INC | 1.2% |
|
CELCUITY INC. | 1.2% |
|
EXACT SCIENCES CORP | 1.2% |
|
NATERA INC | 1.2% |
XBI Underweight Relative to BBP
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |
 |
THERAVANCE BIOPHARMA INC | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.3% |
|
INSMED INC | -2.2% |
|
LEXICON PHARMACEUTICALS, INC. | -2.2% |